The ChEM-H Quarterly, Summer 2024
Sarafan ChEM-H | Stanford University
Sarafan ChEM-H at Stanford University is a hub of innovation that brings the power of diversity to improve human health.
CBI students' research, faculty Q&As, awards, and more.
FUTURE LEADERS IN CHEMICAL BIOLOGY
To transform research, we have to train a new type of interdisciplinary scientist. The Sarafan ChEM-H Chemistry/Biology Interface (CBI) Training Program prepares a diverse new generation of scientists to integrate chemistry, biology, engineering, and clinical sciences with an aim to revolutionize the future of human health research.
Key findings about a major celiac enzyme
CBI student Agnele Sewa , Chaitan Khosla, SLAC researchers and team made new findings about TG2, a key enzyme behind celiac disease. This could aid the development of first-ever drugs for the autoimmune disorder.
New AI approach optimizes antibody drugs
Developed by CBI students Varun Shanker & Theodora Bruun , along with Peter Kim and Brian Hie , the new method more quickly and accurately predicts the molecular changes that will lead to better antibody drugs.
THE MOLECULES OF HEALTH
The scientists at Sarafan ChEM-H are working to improve human health by uncovering the molecular mechanisms that underlie our biology, and learning where those mechanisms go wrong in disease.
Metabolic pathway tied to diet and body weight
A new study led by Wei Wei, Jonathan Z. Long and team reveals that N-acetyltaurine, a byproduct of taurine and acetate, plays an active role in body weight regulation and could lead to improved obesity treatments.
Neutralizing the neutrophil
Neutrophils, a type of immune cell, can attack pathogens by self-destructing, exploding in a process called NETosis. Hawa Racine Thiam is studying NETosis to reduce its damaging effects while retaining its ability to kill real threats.
Glial cells make neurons excitable
Building from a ChEM-H postdoc seed grant, research by Husniye Kantarci , Justin DuBois,?Brad Zuchero, and team reveals that neurons need signals from glia, known as Schwann cells, to become electrically excitable, which could lead to new treatments for chronic pain and epilepsy.
LEARN FROM THE EXPERTS
Hear from two of our Institute Scholars—Jonathan Long and Stanley Qi—on the research that gets them most excited: the science of exercise, and the current state of gene editing.
领英推荐
The future of exercise
Russ Altman interviews Jonathan Z. Long about his work uncovering the molecules produced during exercise, and what that means for the future of understanding weight loss and anti-diabetes treatments.
CRISPR, gene editing and beyond
Bioengineer Lei (Stanley) Qi on the evolution of CRISPR and how it’s “becoming a discipline, a driving force, and a promise that solves long-standing challenges.”
HONORS AND AWARDS
Ponder receives Marsh O’Neill Award for outstanding contributions
Elizabeth Ponder , PhD, Executive Director of Sarafan ChEM-H and the Stanford Innovative Medicines Accelerator (IMA), was recently honored for her exceptional support of Stanford’s scientific research initiatives, strong leadership, and commitment to advancing diversity.
Recent honors
Connect with Us
Sarafan ChEM-H brings together chemists, engineers, biologists, and clinicians to understand life at a molecular level and apply that knowledge to improving human health.
Teaching Assistant, Department of Natural Science, Open University
2 周I'm eagerly waiting to join your team because I admire your research areas.